Profiling the metabolic and physiologic phenotypes of tumors has become important in treatment planning and response monitoring. Here, multimodal imaging methods, including hyperpolarized 13C MRI, 18F-FDG PET, and EPRI imaging, were used to profile the metabolic and physiologic features of human pancreatic ductal adenocarcinoma (PDAC) tumors, Hs766t, MiaPaCa-2, and SU.86.86. PDACs have some of the worst prognoses of all cancers. Experimental results have demonstrated, for the first time, the feasibility and advantages of multimodal metabolic and physiologic assessment of xenograft tumors. This multimodal imaging approach will complement tumor characterization, lead to better prognostics, and earlier response monitoring in cancer treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords